121 related articles for article (PubMed ID: 38548217)
1. IL-1α facilitates GSH synthesis to counteract oxidative stress in oral squamous cell carcinoma under glucose-deprivation.
Ji Y; Zhang Z; Zhao X; Li Z; Hu X; Zhang M; Pan X; Wang X; Chen W
Cancer Lett; 2024 May; 589():216833. PubMed ID: 38548217
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
3. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
[TBL] [Abstract][Full Text] [Related]
5. IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR/JNK/SOX2 pathway.
Yuan SF; Wang YM; Chan LP; Hung AC; Nguyen HDH; Chen YK; Hu SC; Lo S; Wang YY
J Transl Med; 2023 Jul; 21(1):473. PubMed ID: 37461111
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-18a regulates the metastatic properties of oral squamous cell carcinoma cells via HIF-1α expression.
Kim S; Park S; Oh JH; Lee SS; Lee Y; Choi J
BMC Oral Health; 2022 Sep; 22(1):378. PubMed ID: 36064348
[TBL] [Abstract][Full Text] [Related]
7. The expression and functional role of a FOXC1 related mRNA-lncRNA pair in oral squamous cell carcinoma.
Kong XP; Yao J; Luo W; Feng FK; Ma JT; Ren YP; Wang DL; Bu RF
Mol Cell Biochem; 2014 Sep; 394(1-2):177-86. PubMed ID: 24889262
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Potential of Dimethyl Fumarate in Counteract Oral Squamous Cell Carcinoma Progression by Modulating Apoptosis, Oxidative Stress and Epithelial-Mesenchymal Transition.
Basilotta R; Lanza M; Filippone A; Casili G; Mannino D; De Gaetano F; Chisari G; Colarossi L; Motta G; Campolo M; Cuzzocrea S; Paterniti I; Esposito E
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769105
[TBL] [Abstract][Full Text] [Related]
9. Augmented secretion of IL-1α from mouse oral squamous cell carcinoma (OSCC) vcells caused by serum deprivation and hypoxia promotes immune suppressive activity of mesenchymal stromal cells.
Matsunami A; Mizuno-Kamiya M; Kawaki H; Takayama E; Ueno K; Ando M; Morimoto-Ito H; Muramatsu Y; Sumitomo S; Kondoh N
J Oral Biosci; 2021 Sep; 63(3):284-291. PubMed ID: 34153475
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of enzymatic and non-enzymatic antioxidant status and biomarkers of oxidative stress in saliva of patients with oral squamous cell carcinoma and oral leukoplakia: a pilot study.
Babiuch K; Bednarczyk A; Gawlik K; Pawlica-Gosiewska D; Kęsek B; Darczuk D; Stępień P; Chomyszyn-Gajewska M; Kaczmarzyk T
Acta Odontol Scand; 2019 Aug; 77(6):408-418. PubMed ID: 30857448
[No Abstract] [Full Text] [Related]
11. Increased Expression of Tissue/Salivary Transgelin mRNA Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma (OSCC).
Bu J; Bu X; Liu B; Chen F; Chen P
Med Sci Monit; 2015 Aug; 21():2275-81. PubMed ID: 26242444
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract][Full Text] [Related]
13. Elevated VEGFA mRNA levels in oral squamous cell carcinomas and tumor margins: a preliminary study.
Sales CB; Buim ME; de Souza RO; de Faro Valverde L; Mathias Machado MC; Reis MG; Soares FA; Ramos EA; Gurgel Rocha CA
J Oral Pathol Med; 2016 Aug; 45(7):481-5. PubMed ID: 26861159
[TBL] [Abstract][Full Text] [Related]
14. IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma.
Matsuoka Y; Nakayama H; Yoshida R; Hirosue A; Nagata M; Tanaka T; Kawahara K; Sakata J; Arita H; Nakashima H; Shinriki S; Fukuma D; Ogi H; Hiraki A; Shinohara M; Toya R; Murakami R
Br J Cancer; 2016 Nov; 115(10):1234-1244. PubMed ID: 27736845
[TBL] [Abstract][Full Text] [Related]
15. Expression of IL-1α correlates with distant metastasis in patients with head and neck squamous cell carcinoma.
León X; Bothe C; García J; Parreño M; Alcolea S; Quer M; Vila L; Camacho M
Oncotarget; 2015 Nov; 6(35):37398-409. PubMed ID: 26460957
[TBL] [Abstract][Full Text] [Related]
16. TRAIL induces apoptosis in oral squamous carcinoma cells--a crosstalk with oncogenic Ras regulated cell surface expression of death receptor 5.
Chen JJ; Mikelis CM; Zhang Y; Gutkind JS; Zhang B
Oncotarget; 2013 Feb; 4(2):206-17. PubMed ID: 23470485
[TBL] [Abstract][Full Text] [Related]
17. N-acetyltransferase 10 promotes the progression of oral squamous cell carcinoma through N4-acetylcytidine RNA acetylation of MMP1 mRNA.
Liu Y; Huang H; Zhang CB; Fan HN
Cancer Sci; 2023 Nov; 114(11):4202-4215. PubMed ID: 37705232
[TBL] [Abstract][Full Text] [Related]
18. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
[TBL] [Abstract][Full Text] [Related]
19. Repurposing Dihydroartemisinin to Combat Oral Squamous Cell Carcinoma, Associated with Mitochondrial Dysfunction and Oxidative Stress.
Shi S; Luo H; Ji Y; Ouyang H; Wang Z; Wang X; Hu R; Wang L; Wang Y; Xia J; Cheng B; Bao B; Li X; Liao G; Xu B
Oxid Med Cell Longev; 2023; 2023():9595201. PubMed ID: 37273554
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway.
Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y
J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
